Gwagwalada-Zuba, Gwagwalada 902101, Federal Capital Territory, Nigeria
Public hospital, University or academic center
Serves Western Africa

The University of Abuja Teaching Hospital (UATH) is located in Gwagwalada in the Federal Capital Territory of Nigeria. It is a 520-bed hospital with the ability for expansion to 800 beds. UATH is a well-equipped modern tertiary health facility that also provides clinical teachings in all medical fields at undergraduate and post-graduate levels.
Links to previous clinical trials:
Site Capabilities
Clinical Trial Experience
Therapeutic area interests:
Cancer
Infectious diseaseInstitution has received grant(s) from:
National Funder(s)
International Funder(s)Sponsors for previous clinical trials include:
Academic
Government
Industry
Investigator-initiatedPrevious clinical trials conducted:
Behavioral
Diagnostic
Drug – biologic
Drug – small molecule
Epidemiological
Observational
Surgical
VaccineStudy phase capabilities:
Phase I
Phase II
Phase III
Phase IVPediatric research capabilities:
YesInstitution Regulatory/Research Ethics Committees
Frequency of meetings: No data
Application turnaround time (IRB/IEC): 3-4 weeks
Average time from receipt of final protocol to review and approval of study by all relevant committees: No data
Additional compliance:
IRB/IEC in compliance with IC E6(R2) in terms of composition, functions, and operations guidelines
Institution and/or local regulation mandates the distribution of study safety reports to IRB/IECInstitution Staffing Resources
| Staff type | Staff available (y/n) and specialty experience |
|---|---|
| Research coordinator | Yes -Training in Human Subjects Protection (HSP) -Training in Good Clinical Practice (GCP) |
| Research nurse | Yes -Training in Human Subjects Protection (HSP) -Training in Good Clinical Practice (GCP) |
| Research data manager | Yes -Training in Good Clinical Practice (GCP) |
| Quality assurance manager | Not available |
| Biostatisticians | Not available |
| Database programmers | Not available |
| Epidemiologists | Yes |
| Pathologists | Yes |
| Pharmacists | Yes -Experience in Clinical Trials |
Institution Diagnostic Capabilities
Institution has personnel capable of performing diagnostic biopsiesBiopsies performed on-site:
Core needle biopsy
Endoscopic biopsy
Fine needle aspirate
Liquid biopsy
Sentinel lymph node biopsy
Skin biopsy
Surgical biopsyLaboratory basics:
Institution has a laboratory on site
Institution sends diagnostic samples to external laboratory
Institution’s laboratory has been inspected or auditedLaboratory accreditations:
UnknownTests performed on-site:
Complete blood count (CBC) with differential
Comprehensive metabolic-chemistry panel (CMP)
Routine urinalysis
Antibody tests
Antigen tests
Antimicrobial susceptibility and sensitivity
Bacterial smear and culture
Flow cytometry
Fluorescent in situ hybridization (FISH)
Fungal culture
Genetic testing
Histology
Immunohistochemistry (IHC)
Laboratory-developed tests (LDTs)
Microscopy
Ova and parasite (O&P) test
PCR and/or RT-PCR
Other nucleic acid amplification tests (NAATs)
Viral culture
Viral loadImaging capabilities:
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Positron emission tomography (PET)
Nuclear imaging
Ultrasound
X-ray
Pediatric imagingInstitution Research Systems, Recordkeeping, and Data Management
Institution adheres to informed consent processes compliant with ICH E6(R2)
Institution follows ICH E6(R2) for collection and storage of source documentation for paper and/or electronic records
Institution stores patient records/source documents (paper/electronic) in a secured, limited access location during and after the trial
For source documents collected via electronic data capture, institution has a validated system and site procedures that follow ICH E6(R2) 5.5 guidelines
Institution has process in place for proper storage, archiving, and retrieval of essential study document per ICH 8.1
Institution study monitors have full access to source documents or certified copies of source documents (if electronic) if direct access can’t be obtained
Institution has a finance administration team
Institution undergoes routine financial auditsInstitution Pharmacy
Pharmacy on site
Pharmacy has secure, limited access storage area with daily temperature monitoring and backup generator
Pharmacy has standard processes in place to ensure proper receipt, handling, and storage of investigational study drug/vaccine and comparators
Pharmacy has standard processes in place to ensure proper dispensing
Pharmacy has standard processes in place to ensure proper labeling that maintains the study blind
Pharmacy has standard processes in place to ensure proper drug/vaccine accountability, retrieval, and return or destruction of unused product
Institution has a secure, limited-access investigational drug/vaccine storage area with daily temperature monitoring
Institution’s pharmacy has a backup generator sufficient to run necessary equipment, refrigerators, freezers, etc.Institution Equipment
Protocol for managing anaphylactic shock
Institution has a blood bank
Institution carries out blood transfusions for patients that need it
Functioning IV infusion pumps
Functioning basic life support equipment (crash cart)
Functioning electrocardiogram (EKG)Availability of banked blood at institution:
Always available
Occasionally available
Rarely availableInstitution performs the following routine blood screening tests on banked blood:
HIV
HBV
HCV
HPV
HTLVI
HTLVII
SyphilisAdditional information:
Institution’s equipment is calibrated and maintained per manufacturer’s guidelines
Institution’s equipment calibration and maintenance is documented
Institution’s laboratory has a secure, limited access biological specimen storage area with daily temperature monitoring
Institution’s laboratory has a backup power source, with alarm, sufficient to run necessary equipment, refrigerators, freezers, etc.
Institution maintains and uses a diagnostic imaging protocol manual
Laboratory maintains and uses a laboratory protocol manual
Laboratory maintains and uses a laboratory protocol manualProgram-Specific Capabilities

Institution Cancer Treatment Capabilities and Equipment
Treats cancer patients
Performs surgical excisions
Administers chemotherapy
Uses radiation therapyRadiotherapy machines on site:
Linear accelerator
Cobalt 60
Brachytherapy machine
Institution Infectious Disease Treatment Capabilities and Equipment
Treats infectious disease patients
Protocol for managing sepsisVaccines administered on site:
UnknownInfectious disease treatment services performed on site:
Antimicrobial/antibiotic drugs (small molecules or biologics; including antibacterial, antifungal, antiparasitic, antiviral medicines)
Immunotherapies
Supportive care/symptom management
Surgery
Viral load monitoringInvestigators at University of Abuja Teaching Hospital

Habiba Abdullahi, MBBS
Consultant Obstetrician/Gynecologist
CancerOverview
Dr. Abdullahi is a Consultant Obstetrician/Gynecologist at University of Abuja Teaching Hospital and a Fellow of the West African College of Surgeons, Faculty of Obstetrics and Gynecology. She has expertise in gynecological oncology. Her clinical trial interests include drug (biologic and small molecule) and observational studies for cervical, endometrial, and ovarian cancers (which collectively account for a large percentage of Nigeria’s gynecological cancer burden), as well as urogynecology. She has been involved in cancer research since her residency through local and international collaborations.
Formal Clinical Trial Training*
Formal HSP TrainingTrial Phases
Phase III
Phase IVExperience Conducting or Participating in Clinical Trials: Yes
Previous Clinical Trials

Uche Nnebe-Agumadu, MSPH
Professor of Pediatrics and Consultant Pediatrician, University of Abuja Teaching Hospital
CancerOverview
Prof. Nnebe-Agumadu is a Professor of Pediatrics and a Consultant Pediatrician at the University of Abuja Teaching Hospital. In addition to her Master of Science in Public Health (MSPH), she has a Certification in Implementation Science Research. She runs a robust comprehensive sickle cell clinic for families in the Federal Capital Territory and environs. Her clinical trial interests and experience include drug (small molecule) studies for pediatric sickle cell disease and pediatric acute leukemias.
Formal Clinical Trial Training*
Formal HSP TrainingTrial Phases
Phase III
Phase IVExperience Conducting or Participating in Clinical Trials: Yes
Previous Clinical Trials
https://clinicaltrials.gov/study/NCT04624659?id=4202-Hem-301&rank=1#study-overview
*Definitions
- HSP – Human Subjects Protection
- GCP – Good Clinical Practice
- GCLP – Good Clinical Laboratory Practice
